CHINA / SOCIETY
China moves to prevent ‘immunity gap’ with other countries By GT staff reporters Published: Jan 08, 2021 09:26 PM Updated: Jan 08, 2021 10:48 PM
Sinovac vaccine photo
China s Sinovac s COVID-19 vaccine revealed on Thursday 78 percent efficacy rate and 100 percent protection against severe coronavirus infections in Phase III trials conducted in Brazil, bringing it closer to its domestic approval for the market and raises hopes for the second effective Chinese vaccine to be widely used, experts said.
The Brazilian Health Minister announced on Thursday the country would purchase 100 million doses of Sinovac s vaccine called CoronaVac for the Brazilian national immunity plan scheduled to start on January 25, following other developing countries, such as Indonesia, Malaysia and the United Arab Emirates, to secure Chinese inactivated vaccines in national inoculation.